Umb Bank, N.A. Pfizer Inc Transaction History

Umb Bank, N.A.

$6.3 Billion
Q3 2024

A detailed history of Umb Bank, N.A. transactions in Pfizer Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 380,403 shares of PFE stock, worth $10.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

380,403

Previous 194,685 95.39%

Holding current value

$10.1 Million

Previous $5.45 Million 102.09%

% of portfolio

0.17%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$27.7 - $31.39 $5.14 Million - $5.83 Million	185,718 Added 95.39%	380,403 $11 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $1.22 Million - $1.43 Million	-48,290 Reduced 19.87%	194,685 $5.45 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $2.41 Million - $2.77 Million	-93,168 Reduced 27.72%	242,975 $6.74 Million
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $5.29 Million - $6.88 Million	-202,585 Reduced 37.6%	336,143 $9.68 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $923,100 - $1.08 Million	-28,766 Reduced 5.07%	538,728 $17.9 Million
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $531,072 - $614,438	-14,703 Reduced 2.53%	567,494 $20.8 Million
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $19,576 - $25,486	497 Added 0.09%	582,197 $23.8 Million
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $1.4 Million - $1.83 Million	-33,490 Reduced 5.44%	581,700 $29.8 Million
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $1.2 Million - $1.47 Million	-27,535 Reduced 4.28%	615,190 $26.9 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $357,350 - $423,705	-7,680 Reduced 1.18%	642,725 $33.7 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $209,626 - $259,753	-4,582 Reduced 0.7%	650,405 $33.7 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $6.73 Million - $9.98 Million	162,931 Added 33.11%	654,987 $38.7 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $171,051 - $219,730	4,358 Added 0.89%	492,056 $21.2 Million
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $258,049 - $292,326	-7,186 Reduced 1.45%	487,698 $19.1 Million
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $231,014 - $260,537	-6,898 Reduced 1.37%	494,884 $17.9 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $771,650 - $981,220	-23,055 Reduced 4.39%	501,782 $18.5 Million
Q2 2020 Jul 16, 2020	SELL	$30.12 - $36.54 $427,312 - $518,392	-14,187 Reduced 2.63%	524,837 $17.2 Million
Q1 2020 May 26, 2020	BUY	$27.03 - $38.62 $325,954 - $465,718	12,059 Added 2.29%	539,024 $17.6 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $406,825 - $461,694	12,358 Added 2.4%	526,965 $20.6 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $521,529 - $676,270	16,052 Added 3.22%	514,607 $18.5 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $600,481 - $674,201	-16,238 Reduced 3.15%	498,555 $21.6 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $1.37 Million - $1.51 Million	-36,542 Reduced 6.63%	514,793 $21.9 Million
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $974,214 - $1.11 Million	25,324 Added 4.81%	551,335 $24.1 Million
Q3 2018 Oct 22, 2018	BUY	$34.47 - $41.81 $5.77 Million - $6.99 Million	167,293 Added 46.64%	526,011 $23.2 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $100,094 - $106,710	3,035 Added 0.85%	358,718 $13 Million
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $10,211 - $11,846	320 Added 0.09%	355,683 $12.6 Million
Q4 2017 Jan 22, 2018	SELL	$33.26 - $35.29 $99,846 - $105,940	-3,002 Reduced 0.84%	355,363 $12.9 Million
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $11.1 Million - $12.2 Million	358,365	358,365 $12.8 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account